Adrenal incidentalomas: indications for surgery.

Chir Ital

Department of Surgical Sciences, Surgical Semeiotics Unit, University of Udine, Udine.

Published: December 2003

Adrenalectomy represents the gold standard treatment for hyperfunctioning adrenal incidentaloma. In cases of silent adrenal masses, on the other hand, the surgical removal of an adrenocortical cancer entails the sacrifice of a large number of safe benign masses, and in most cases surgery is therefore unjustified. The aim of this paper was to clarify the surgical indications for adrenal incidentaloma by reviewing our experience in comparison with the main reference literature. Over the period from 1995 to 2001 we managed 40 cases of incidentaloma. US and CT abdominal scans, adrenal scintigraphy and biochemical tests were performed on an outpatient basis. Seven pre-Cushing syndromes were removed. Ten incidentalomas measured 4 cm or more in diameter: 5 of these were operated on and in 5 cases surgery was not feasible or was refused. Only one malignant mass was detected (an angiosarcoma). Four postoperative minimal complications (18.7%) were observed. The follow-up (median: 48 months) was uneventful. The surgical approach was traditional in 11 cases and laparoscopic in 1 case. Surgery should be considered mandatory in cases of hyperfunctioning adrenal masses in the presence of suspect radiological evidence, in cases of discordant CT and scintigraphy findings and when the maximum diameter is 4 cm or more.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hyperfunctioning adrenal
8
adrenal incidentaloma
8
adrenal masses
8
cases surgery
8
cases
7
adrenal
6
adrenal incidentalomas
4
incidentalomas indications
4
surgery
4
indications surgery
4

Similar Publications

Adrenocortical Carcinoma: A Challenging Diagnosis.

Cureus

October 2024

Internal Medicine, Unidade Local de Saúde Viseu Dão-Lafões, Viseu, PRT.

Adrenocortical carcinoma (ACC) is a rare malignancy with aggressive behaviour and a poor prognosis. Patients can present with adrenal hormonal excess or with nonspecific symptoms driven by the presence of an abdominal mass or metastatic disease. Many are completely asymptomatic and diagnosed incidentally.

View Article and Find Full Text PDF

Adrenocortical disorders encompass a broad spectrum of conditions ranging from benign hyperplasia to malignant tumors, significantly disrupting hormone balance and causing a variety of clinical manifestations. By leveraging next-generation sequencing and in silico analyses, recent studies have uncovered the genetic and molecular pathways implicated in these transitions. In this review, we explored the molecular and genetic alterations in adrenocortical disorders, with a particular focus on the transitions from normal adrenal function to hyperfunction.

View Article and Find Full Text PDF

Mesenteric paragangliomas (PGLs) are extremely rare, with a limited number of reported cases. These tumors are typically non-functioning and commonly manifest as a palpable abdominal mass or abdominal pain; however, a significant proportion of patients remain asymptomatic. Despite their rarity, they should be considered in the differential diagnosis of mesenteric masses.

View Article and Find Full Text PDF

Objective Cortisol-producing adenoma (CPA) is a major subtype of functional adrenal tumors. CPAs are generally treated with adrenalectomy; however, it is difficult to predict the ideal duration of glucocorticoid replacement after resection. This study explored pre-operative factors predictive of glucocorticoid replacement therapy duration after CPA resection.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!